Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Becton, Dickinson and Company    BDX

BECTON, DICKINSON AND COMPANY

(BDX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
05/21/2020 05/22/2020 05/26/2020 05/27/2020 05/28/2020 Date
238.94(c) 239.25(c) 233.14(c) 234.8(c) 241.5(c) Last
8 333 175 11 783 282 3 585 790 3 733 094 1 788 389 Volume
-1.67% +0.13% -2.55% +0.71% +2.85% Change
More quotes
Financials (USD)
Sales 2020 16 922 M - -
Net income 2020 1 248 M - -
Net Debt 2020 16 080 M - -
P/E ratio 2020 50,5x
Yield 2020 1,41%
Sales 2021 18 222 M - -
Net income 2021 2 682 M - -
Net Debt 2021 13 735 M - -
P/E ratio 2021 24,5x
Yield 2021 1,53%
Capitalization 71 439 M 71 439 M -
EV / Sales 2020 5,17x
EV / Sales 2021 4,67x
Nbr of Employees 70 093
Free-Float 79,3%
More Financials
Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (52.4%): surgical instruments (71.6% of net sales), pharmaceutical systems (16.2%), and diabetes care products (12.2%); - diagnostic materials (24.9%): automated systems for blood testing, mycobacteria... 
More about the company
Surperformance© ratings of Becton, Dickinson and Comp
Trading Rating : Investor Rating :
More Ratings
Latest news on BECTON, DICKINSON AND COMP
05/28BECTON DICKINSON AND : Q2 2020 Earnings Info Graphic
PU
05/26BECTON DICKINSON & CO : Material Modification to Rights of Security Holders, Ame..
AQ
05/26BECTON DICKINSON AND : BD to Present at Jefferies Virtual Healthcare Conference
PR
05/21BECTON DICKINSON AND : BD Prices Offerings of $1.5 Billion of Common Stock and $..
PR
05/20BECTON DICKINSON & CO : Creation of a Direct Financial Obligation or an Obligati..
AQ
05/20BECTON DICKINSON AND : Q2 2020 Earnings Presentation
PU
05/19BECTON DICKINSON AND : BD Announces Offerings of $1.5 billion of Common Stock an..
PR
05/13BECTON DICKINSON & CO : Other Events, Financial Statements and Exhibits (form 8-..
AQ
05/07BECTON DICKINSON AND : & CO Management's Discussion and Analysis of Financial Co..
AQ
05/07BECTON DICKINSON : Fiscal 2Q Earnings Snapshot
AQ
05/07BECTON DICKINSON & CO : Results of Operations and Financial Condition, Financial..
AQ
05/07BECTON DICKINSON AND : BD Announces Results For 2020 Second Fiscal Quarter; With..
PR
05/07BECTON, DICKINSON AND COMPANY : SEC Filing 8K
CO
05/07BECTON, DICKINSON AND COMPANY : Slide show half-year results
CO
05/07BECTON, DICKINSON AND COMPANY : Half-year results
CO
More news
News in other languages on BECTON, DICKINSON AND COMP
05/04BECTON, DICKINSON AND COMPANY : Veröffentlichung des Halbjahresergebnisses
05/04BECTON, DICKINSON AND COMPANY : publication des résultats semestriels
03/09BECTON, DICKINSON AND COMPANY : Ex-dividend day for
02/04BECTON, DICKINSON AND COMPANY : Veröffentlichung des Quartalsergebnisses
02/04BECTON, DICKINSON AND COMPANY : publication des résultats trimestriels
More news
Chart BECTON, DICKINSON AND COMPANY
Duration : Period :
Becton, Dickinson and Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BECTON, DICKINSON AND COMP
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 273,94 $
Last Close Price 241,50 $
Spread / Highest target 24,2%
Spread / Average Target 13,4%
Spread / Lowest Target 1,45%
EPS Revisions
Managers
NameTitle
Thomas E. Polen President, Chief Executive Officer & Director
Vincent A. Forlenza Executive Chairman
Christopher R. Reidy Chief Financial Officer, CAO & EVP-Administration
John A. DeFord Chief Technology Officer & Executive VP
William R. Sigmund Chief Medical Officer & EVP
Sector and Competitors
1st jan.Capitalization (M$)
BECTON, DICKINSON AND COMPANY-11.20%71 439
COLOPLAST A/S33.77%34 856
TELEFLEX INCORPORATED-4.82%16 634
HARTALEGA HOLDINGS103.28%8 675
TOP GLOVE CORPORATION BHD.178.72%7 857
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED33.19%7 257